Polkadot approves 2,1 billion DOT limit to reinforce scarcity
- Polkadot sets a hard cap of 2,1 billion DOT
- Model replaces unlimited annual issuance of 120 million
- DAO approves proposal with 81% of favorable votes
The Polkadot DAO approved the 1710 referendum proposal to cap the supply of DOT tokens at 2,1 billion, replacing the unlimited issuance model that minted approximately 120 million tokens per year with no defined cap. This measure marks a significant shift in the network's tokenomics, creating greater scarcity in the long term.
According to the DAO's official X post, the proposal received 81% community approval. The new system provides for a two-year inflation schedule, gradually reducing emissions and projecting a significantly smaller total supply compared to the previous model.
🚨 DOT supply → capped at 2.1 Billion 🚨
The Polkadot DAO has signaled support for a hard cap, by passing Referendum 1710 on the “Wish For Change” track, with 81% in favor.
Today ⤵️
→ 1.6 Billion DOT exist
→ 120M DOT/year minted each year
→ No supply capWhat Ref. 1710… pic.twitter.com/OJMtDumAZC
— Polkadot (@Polkadot) September 14, 2025
According to calculations released by Polkadot itself, if the referendum 1710 is maintained, the supply of DOT is expected to reach approximately 1,91 billion by 2040, while the unlimited annual issuance model would bring the total to 3,4 billion in the same period.
The change was interpreted as a way to align the protocol's monetary policy with the growing demand for greater predictability and sustainability in token issuance. The adjustment aims to provide greater clarity for investors and ecosystem users, reinforcing the value of decentralized governance.
Polkadot's governance system, known as OpenGov, launched in 2023, allows any DOT holder to submit proposals, vote, or delegate decision-making power. This format was essential for the approval of the change, which is now part of the network's rules.
Despite the news, the market's reaction was mixed in the short term. DOT fell 2,2% in the last 24 hours, trading at $4,32, although it has gained 9,8% in the last week. The token's market capitalization is estimated at $6,6 billion.
The decision to limit the supply of DOT brings Polkadot into line with other projects that adopt programmed scarcity policies, seeking greater stability and attractiveness for participants in the cryptocurrency sector and DeFi protocols operating on its network.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wall Street Stands Guard as Bessent Strikes Again: Aftereffects of August's "Treasury Turnaround" Persist, November Refinancing Notice Could Be the Next Flashpoint
As the US Treasury prepares to update its debt management plan in November, key clues may emerge on Friday.
"Coca-Cola belief" never goes out of style! KFC in America says goodbye to Pepsi and embraces Coca-Cola (KO.US); Buffett-style "boring investment" returns to the spotlight
KFC has chosen Coca-Cola as its soda supplier in the United States, abandoning its long-term partner Pepsi. As of the close of the U.S. stock market on Thursday, Coca-Cola's (KO.US) stock price reached a record high, defying the ongoing declines in global tech stocks, especially in the semiconductor and broad AI computing sectors.
AI financing concerns weigh heavily on chip stocks, global tech sector has lost over $1 trillion this week
Multiple pressures, including rising expectations of a Federal Reserve rate hike and increasing AI financing costs, have led to a massive sell-off in global tech stocks this week. The combined market value of the world's top 20 AI and semiconductor stocks has evaporated by more than $1 trillion, and the semiconductor ETF (SOXX) has recorded its longest losing streak in 11 years. On Thursday, SK Hynix continued to plunge by over 10% in a single day, while Nvidia, Samsung, and SoftBank were not spared.
Safe Haven Amid AI Crash! Major Pharmaceutical Stocks Approach Historic Highs
Amid concerns over AI capital expenditures, funds are seeking a "certainty premium." State Street Healthcare ETF reached a record high. Eli Lilly and AbbVie are both approaching their historical highest closing prices, while Gilead and Amgen have surged 7.7% and 7.2% respectively over the past five days. Eli Lilly continues to bet on the future through its GLP-1 dominance and 40 M&A deals totaling $20 billion. AbbVie's core drug Skyrizi has shown positive data for its new subcutaneous formulation, which is expected to extend its patent and drive additional sales.
Crypto prices
More
